← Eichor
Study identifier: NCT03945305 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension

Condition: Essential Hypertension  ·  Sponsor: Yi Yang

PhaseNA
Planned participants500
Who can joinAll sexes, 30 Years to 75 Years
Healthy volunteersNo

About this study

The purpose of this study is to explore the efficacy and safety of remote ischemic conditioning for essential hypertension in the community population.

This description comes directly from the study's public registry record.

Talk to the study team

Yi Yang, MD,PhD  ·  0086-13756661217  ·  doctor_yangyi@163.com

Zhen-Ni Guo, MD  ·  zhen1ni2@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

First Hospital of Jilin UniversityChangchun, Jilin, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03945305